Stocks Health care NTRA
NASDAQ · Health careNatera, Inc. (NTRA)
Natera, Inc. brought in $2.7B of revenue over the twelve months to June 30, 2026, up 37.8% from a year earlier. It posted a net loss of $192.3M. Operating cash flow minus capital spending left $109.1M of free cash flow in fiscal 2025. At June 30, 2026 it held $1.1B in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.
What Natera, Inc. does
Natera provides cell-free DNA testing services for women's health, oncology, and organ health. Its offerings include non-invasive prenatal tests, carrier screenings, hereditary cancer screenings, minimal residual disease monitoring for cancer patients, and donor-derived cell-free DNA tests for kidney and heart transplant recipients. Its shares trade on NASDAQ under the ticker NTRA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $2.3B | -$208.2M | -$1.52 | $109.1M |
| 2024 | $1.7B | -$190.4M | -$1.53 | $69.2M |
| 2023 | $1.1B | -$434.8M | -$3.78 | -$286.2M |
| 2022 | $820.2M | -$547.8M | -$5.57 | -$479.2M |
| 2021 | $625.5M | -$471.7M | -$5.21 | -$376.3M |
| 2020 | $391M | -$229.7M | -$2.84 | -$202.1M |
Latest SEC filings
What Natera, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 7, 2026
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- July 6, 2026
- June 16, 2026
- June 16, 2026
- June 5, 2026
- May 8, 2026Quarterly report 10-Q · period to March 31, 2026
- May 7, 2026
Questions about NTRA
What does Natera, Inc. do?
Natera provides cell-free DNA testing services for women's health, oncology, and organ health. Its offerings include non-invasive prenatal tests, carrier screenings, hereditary cancer screenings, minimal residual disease monitoring for cancer patients, and donor-derived cell-free DNA tests for kidney and heart transplant recipients. Its shares trade on NASDAQ under the ticker NTRA.
Is Natera, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $192.3M on revenue of $2.7B.
How much revenue does Natera, Inc. make?
Over the twelve months to June 30, 2026 Natera, Inc. reported revenue of $2.7B. That is 37.8% more than a year earlier.
When did Natera, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 25, 2026.
Similar companies
Follow NTRA
Get an email when Natera, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow NTRA: get an email when it filesWhere the numbers come from
Financial figures are the values Natera, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.